Iran ranks among the world’s top 10 pharmaceutical producers
Amin-Reza Khaleghian, the Director General of Communications and International Affairs at Pardis Technology Park (PTP), announced that Iran has joined the top ten global pharmaceutical producers, distinguished by its diverse portfolio of drugs.
Khaleghian highlighted Iran’s position as the sixth leading producer of multiple sclerosis (MS) medications worldwide and its breakthrough in treating cutaneous leishmaniasis. He emphasized that Iran has pioneered a novel treatment for migraines, thanks to the collaborative efforts of both public and private sectors that led to the establishment of PTP.
PTP, a hub for innovation, hosts 400 technology and knowledge-based companies that have engaged in product and technology exchanges with 40 countries. PTP’s primary roles include assisting companies in sourcing raw materials and marketing their products internationally.
The Vice Presidency of Science and Technology Affairs has established technology offices in several countries, including Kenya, Venezuela, Turkey, and Georgia, further expanding PTP’s global footprint. Khaleghian also mentioned PTP’s membership in the International Association of Science Parks and Areas of Innovation (IASP), where he serves as the chairman of the West Asia and North Africa (WANA) division.
Despite sanctions, PTP has made significant strides, including the domestic production and export of broadcast transmitters and the successful use of Iranian-made ventilators for four years without any issues.
Khaleghian expressed optimism for increased cooperation with Saudi Arabia, Iraq, and Indonesia in the near future and affirmed Iran’s commitment to developing cooperation with Russia in the health, pharmaceutical, and Fintech sectors, despite the sanctions imposed on both countries.